With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
An alternative take.
On the RO-APM as summarized by a health economist, who thinks it’s an excellent fiscal policy to financially incentivize less expensive therapies by standardizing repayments based on diagnosis rather than treatment modality with mandatory participation. | Howard, JAMA 2019